Abstract:BACKGROUNDLaser interstitial thermal therapy (LITT) is a minimally invasive means of tumor cyto-destruction with the potential for additional clinical benefits, such as altering the blood-brain barrier or the brain tumor microenvironment (TME). Using a murine model of GBM, we utilized a clinically relevant laser ablation model to identify and exploit immune TME changes after LITT to generate therapies that improve mouse survival, with the potential for rapid clinical translation. METHODSRight frontal lobe implantation of the immune "cold" SB28 murine glioma cells were performed in C57BL/6J mice. Tumor location was verified by MRI followed by stereotactic insertion of a paired fiberoptic laser and thermocouple to perform real-time hyperthermic ablation with temperature monitoring. Pulsed laser application maintained a peri-lesional temperature of 44°C for 150-180 seconds. Following LITT (or sham surgery), spectral flow cytometry was used to profile the immune TME. Survival studies were performed using a combination of LITT and immune modulating therapies. RESULTSLaser ablation alone provided a survival benefit compared to sham surgery (median survival: 29 vs 22.5 days, P<0.0001) in in glioma-bearing mice. Survival studies combining LITT with anti-PD1 lacked a significant response in the SB28 model but showed some long-term survivors. Flow cytometry performed on brain tissue post-LITT days 3 and 7 demonstrated little to no change in CD4+/CD8+ T cell responses but did show an increase in neutrophils, which expressed TLR2 and 4. The TME showed negligible numbers of phagocytic cells with obvious tumor cell uptake post-LITT. Using these results, we generated strategies for LITT-based combination immune therapies. Survival studies are ongoing using combinations of LITT/anti-PD1 with neutrophil depletion, inhibition of anti-CD47, and addition of broad TLR2/4 agonists as a neutrophil stimulus. CONCLUSIONSA clinically relevant immunocompetent murine LITT model enables the generation of novel treatment strategies with potential for rapid clinical translation.

Ctni-52. Expedited Chemoradiation After Laser Interstitial Thermal Therapy (Litt) Is Feasible And Safe In Patients With Newly Diagnosed Glioblastoma

Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma.

Efficacy of Laser Interstitial Thermal Therapy (LITT) for Newly Diagnosed and Recurrent IDH Wild-type Glioblastoma

Laser Interstitial Thermal Therapy for First-Line Treatment of Surgically Accessible Recurrent Glioblastoma: Outcomes Compared With a Surgical Cohort

Surg-49. Investigating Litt-Based Combination Therapies In Preclinical Glioma Models

Surg-48. Laser Interstitial Thermal Therapy Remodels The Tumor Immune Landscape In A Mouse Glioma Model

204 Laster Interstitial Thermal Therapy for Primary and Recurrent Meningioma: A Prospective and Retrospective Multi-institutional Study

Evaluating the efficacy and clinical outcomes of minimally invasive laser interstitial thermal therapy in the treatment of recurrent glioblastoma multiforme: meta-analysis protocol

Laser Interstitial Thermal Therapy in Grade 2/3 IDH1/2 Mutant Gliomas: A Preliminary Report and Literature Review

Safety and Efficacy of Laser Interstitial Thermal Therapy as Upfront Therapy in Primary Glioblastoma and IDH-Mutant Astrocytoma: A Meta-Analysis

Multiple Glioblastomas Ablation by Laser Interstitial Thermal Therapy (LITT): A Rare Case

Establishment of C6 Brain Glioma Models Through Stereotactic Technique for Laser Interstitial Thermotherapy Research

Efficacy of laser interstitial thermal therapy for biopsy-proven radiation necrosis in radiographically recurrent brain metastases

Disp-01. Factors Affecting Post-Ablation Outcomes And Trial Enrollment In Diverse Patients Undergoing Laser Interstitial Thermal Therapy

Tmod-27. Recurrent Glioblastoma After Laser Ablation Of The Primary Tumor In A Preclinical Orthotopic Model Exhibit Increased Genetic Signatures Of Cell Cycle And Cell Motility

Adaptation of laser interstitial thermal therapy for tumor ablation under MRI monitoring in a rat orthotopic model of glioblastoma

Phase 1 study of concomitant tumor treating fields and temozolomide chemoradiation for newly diagnosed glioblastoma

Combinatorial Checkpoint Blockade and Laser Interstitial Thermal Therapy: A Single Center Study

Biom-56. Heat Shock Proteins Predict Clinical Response And Potentiate Local Immunogenicity After Litt For Glioblastoma

376 Laser Interstitial Thermal Therapy for Deep-Seated Perivascular Brain Tumors: Evaluating the Risk of Distal Ischemia

Innv-32. Laser Interstitial Thermal Therapy Followed By Consolidation Stereotactic Radiosurgery (Litt-Csrs) In Patients With Newly Diagnosed Brain Metastasis